Literature DB >> 15088070

p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.

S Hara1, S Nakashima, T Kiyono, M Sawada, S Yoshimura, T Iwama, Y Banno, J Shinoda, N Sakai.   

Abstract

Although the p53 tumor-suppressor gene product plays a critical role in apoptotic cell death induced by DNA-damaging chemotherapeutic agents, human glioma cells with functional p53 were more resistant to gamma-radiation than those with mutant p53. U-87 MG cells with wild-type p53 were resistant to gamma-radiation. U87-W E6 cells that lost functional p53, by the expression of type 16 human papillomavirus E6 oncoprotein, became susceptible to radiation-induced apoptosis. The formation of ceramide by acid sphingomyelinase (A-SMase), but not by neutral sphingomyelinase, was associated with p53-independent apoptosis. SR33557 (2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxybphenethyl)amino]propyloxy)benzene-sulfonyl) indolizine, an inhibitor of A-SMase, suppressed radiation-induced apoptotic cell death. In contrast, radiation-induced A-SMase activation was blocked in glioma cells with endogenous functional p53. The expression of acid ceramidase was induced by gamma-radiation, and was more evident in cells with functional p53. N-oleoylethanolamine, which is known to inhibit ceramidase activity, unexpectedly downregulated acid ceramidase and accelerated radiation-induced apoptosis in U87-W E6 cells. Moreover, cells with functional p53 could be sensitized to gamma-radiation by N-oleoylethanolamine, which suppressed radiation-induced acid ceramidase expression and then enhanced ceramide formation. Sensitization to gamma-radiation was also observed in U87-MG cells depleted of functional p53 by retroviral expression of small interfering RNA. These results indicate that ceramide may function as a mediator of p53-independent apoptosis in human glioma cells in response to gamma-radiation, and suggest that p53-dependent expression of acid ceramidase and blockage of A-SMase activation play pivotal roles in protection from gamma-radiation of cells with endogenous functional p53.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088070     DOI: 10.1038/sj.cdd.4401428

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  41 in total

Review 1.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 2.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

Review 3.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

4.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.

Authors:  Yoshiko Masuda; Manabu Futamura; Hiroki Kamino; Yasuyuki Nakamura; Noriaki Kitamura; Shiho Ohnishi; Yuji Miyamoto; Hitoshi Ichikawa; Tsutomu Ohta; Misao Ohki; Tohru Kiyono; Hiroshi Egami; Hideo Baba; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2006-08-02       Impact factor: 3.172

Review 5.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 6.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

7.  Targeting acid sphingomyelinase with anti-angiogenic chemotherapy.

Authors:  Jeanna Jacobi; Mónica García-Barros; Shyam Rao; Jimmy A Rotolo; Chris Thompson; Aviram Mizrachi; Regina Feldman; Katia Manova; Alicja Bielawska; Jacek Bielawska; Zvi Fuks; Richard Kolesnick; Adriana Haimovitz-Friedman
Journal:  Cell Signal       Date:  2016-10-01       Impact factor: 4.315

8.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 9.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

Review 10.  Molecular targeting of acid ceramidase: implications to cancer therapy.

Authors:  Youssef H Zeidan; Russell W Jenkins; John B Korman; Xiang Liu; Lina M Obeid; James S Norris; Yusuf A Hannun
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.